Objectives: To prospectively evaluate the outcome of patients with low-risk papillary thyroid
carcinoma treated with total thyroidectomy (TT) who did not undergo radioiodine remnant …

Background The aim of this study is to compare the effectiveness of 131 I therapy between
three groups of DTC patients who received 30, 60 or 100 mCi for thyroid remnant ablation …

Background It is not known whether low-dose radioiodine (1.1 GBq [30 mCi]) is as effective
as high-dose radioiodine (3.7 GBq [100 mCi]) for treating patients with differentiated thyroid …

The role of Iodine-131 therapy is well established as an adjuvant therapy and for thyroid
remnant ablation in differentiated thyroid cancer (DTC); however controversy still exists …

Background: Radioactive iodine (RAI) remnant ablation has been used to eliminate normal
thyroid tissue and may also facilitate monitoring for persistent or recurrent thyroid carcinoma …

Background After initial radioactive iodine (RAI) treatment in differentiated thyroid cancer
patients, we sometimes observe a star-shaped region of intense uptake of 131 I on whole …

Objective Remnant thyroid ablation is crucial in the management of patients with
differentiated thyroid cancer. However, the optimal dose of radioactive 131 I for ablation is …

The lack of isolation ward throughout Japan has long been limiting the 131 I radioactive
iodine (RAI) ablation for differentiated thyroid cancer (DTC) cases. The 30 mCi RAI ablation …

Background. The purpose of the meta-analysis was to estimate the effectiveness and toxicity
of low activity radioiodine ablation versus high activity in patients with differentiated thyroid …

Objective To identify prognostic factors associated with a low-iodine diet (LID) and the
amount of remnant thyroid tissue in Japanese patients with differentiated thyroid cancer …